singular genomics stock

Research & Science Based on 39 salaries Scientist II 5 salaries Scientist 5 salaries View More Engineering Based on 11 salaries QC Associate II 2 salaries Sr Engineer . Announces Pricing of Upsized Initial Public Offering of Common Stock. Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. window.hsFormsOnReady.push(()=>{ We are advancing genomics, together. Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. Defense. Copy and paste multiple symbols separated by spaces. Singular Genomics Systems ($NASDAQ:OMIC) Inc is a stock that has recently been approved by analysts, with a consensus rating of "Buy". Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. formId: "6d6c14f2-ba94-427d-bb5a-a595d4237b34", These symbols will be available throughout the site during your session. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. Stock Markets. Data is subject to change. This is a profile preview from the PitchBook Platform. Most importantly, the business is set up for success with the right team, the right product, and the right opportunity. Read More. These risks and uncertainties include and are not limited to the following: (i) we have incurred significant losses since inception, we expect to incur significant losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability; (ii) we have very little history manufacturing and commercializing our products or technology; (iii) the life sciences technology market is highly competitive, and if we fail to compete effectively, our business and operating results will suffer; (iv) if we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our products; (v) if our products fail to achieve early customer and scientific acceptance, we may not be able to achieve broader market acceptance for our products, and our revenues and prospects may be harmed; (vi) we expect to be highly dependent upon revenue generated from the sale of the G4 and planned PX, and any delay or failure by us to successfully manufacture and commercialize the G4 and planned PX could have a substantial adverse effect on our business and results of operations; and (vii) the COVID-19 pandemic, efforts to reduce its spread and recent macroeconomic challenges have adversely impacted, and may materially and adversely impact, our business, operations and product manufacturing and commercialization objectives. What is Singular Genomics Systems Inc's EBITDA? Compare Top Brokerages Here. The low in the last 52 weeks of Singular Genomics Systems stock was 1.08. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 2023 Singular Genomics. With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING! If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). 22.60% of the stock of Singular Genomics Systems is held by insiders. General +1 (858) 333-7830 info@singulargenomics.com. It develops two integrated solutions: G4 Instrument and PX Instrument. 10X GENOMICS, INC. : Nieuws en informatie aandeel 10X GENOMICS, INC. | 1KJ | Deutsche Boerse AG The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Cash, cash equivalents and short-term investments, excluding restricted cash, as of December 31, 2022 totaled $244.6million. The bid size displays the total amount of desired shares to buy at that price, and the ask size is the number of shares offered for sale at that price. Raising the bar with industry-leading run times across applications. Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. 21,081 followers. On average, they predict the company's stock price to reach $3.50 in the next year. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. May-26-21 11:56PM. 2023, Nasdaq, Inc. All Rights Reserved. The average price target represents a 118.45% change from the last price of $1.03. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. Eurofins Genomics, with a market share of around 16.2%, is the second largest player in the genomic testing market. Singular Genomics Systems Inc stock price today is $1.08. Singular Genomics Systems has a P/B Ratio of 0.30. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. On September 30, 2021 (the Closing Date), Singular Genomics Systems, Inc. refinanced its existing loan with Silicon Valley Bank (the "Lender"). Stoke Therapeutics Inc. It now looks like their preparing for an IPO and have filed an S-1. A high-level overview of Singular Genomics Systems, Inc. (OMIC) stock. What was Singular Genomics Systems Inc stock price yesterday? You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. Active, Closed, Last funding round type (e.g. Construction and Engineering. Not an offer or recommendation by Stocktwits. It does not include securities convertible into the common equity securities. Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path of discovery without limits. To explore Singular Genomicss full profile, request access. When is Singular Genomics Systems' next earnings date? 4 Analysts Have This to Say About Singular Genomics Sys. What is the 52-week low for Singular Genomics Systems Inc? Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. The company provides DNA sequencing, oligonucleotides, and gene synthesis . August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. Our mission is to accelerate genomics for the advancement of science and medicine. window.hsFormsOnReady = window.hsFormsOnReady || []; Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. The big shareholder groups in Singular Genomics Systems, Inc. (NASDAQ:OMIC) have power over the company. Lorsque vous utilisez nos sites et applications, nous utilisons des, authentifier les utilisateurs, appliquer des mesures de scurit, empcher les spams et les abus; et. The company has a market capitalization of . Singular Genomics Systems Inc market cap is $77.7M. Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing, are . Jan. 7, 2022, 04:18 PM Singular Genomics Systems Inc (NASDAQ:OMIC) launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter. The Stock That Is Flying Under Wall St. Radar (Ad). Singular Genomics Systems, Inc. (Name of Issuer) Common Stock par value $0.0001 per share (Title of Class of Securities) 82933R100 . Singular Genomics Systems Stock Performance. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. High institutional ownership can be a signal of strong market trust in this company. System throughput depends on sequencing application and flow cell. Join The Team Our Story Where We Started At Singular, we are on a mission to accelerate genomics for the advancement of science and medicine. A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M Measures how much net income or profit is generated as a percentage of revenue. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. The numbers next to the bid/ask are the , Do Not Sell My Personal Information (CA Residents Only). It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. Net loss for the fourth quarter of 2022 was$21.1 million, or a loss of $0.29 per common share, comparedto $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021. A high percentage of insider ownership can be a sign of company health. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). Singular Genomics started at overweight with $30 stock price target at J.P. Morgan. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended December 31, 2022. What was the 52-week high . The Stock That Is Flying Under Wall St. Radar. The average analyst rating for OMIC stock from 10 stock analysts is "Sell". Add to Watchlist 1.03-0.07 (-6.36%) Apr 12, 2023, 2:52 PM EDT - Market open. portalId: 20463371, Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its quarterly earnings data on Tuesday, November, 9th. Type a symbol or company name. 326 E 8th St #105, Sioux Falls, SD 57103 Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. Singular Genomics Systems does not currently pay a dividend. Real-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. GlobeNewswire. USD. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. 2023 PitchBook. Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Charles Schwab's Recovery Just Shifted Gears, Digital Realty Offers Growth and Income with a Wide Moat, These 2 Fabless Chip Stocks Are Among The Market's Top Performers, Why State Street Stock Is Sliding After Announcing Earnings, The Top 2 Chip Stocks Going Into Earnings Season, Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs, Why Restaurant Stocks are the Stocks to Buy Right Now, Founder, CEO, Pres & Chairperson of the Board, Founder, Member of Scientific Advisory Board & Independent Director, Founder, Chief Scientific Officer & Chair of Scientific Advisory Board, BREAKING: Tiny biotech successfully treats blindness. What is Market Cap of Singular Genomics Systems Inc? Matt Clawson949-370-8500ir@singulargenomics.com, Dan Budwick, 1AB973-271-6085dan@1abmedia.com, Singular Genomics Systems, Inc.Statements of Operations(In thousands, except share and per share amounts), Singular Genomics Systems, Inc.Balance Sheets(In thousands, except share and par value amounts). The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Complete Singular Genomics Systems Inc. stock information by Barron's. View real-time OMIC stock price and news, along with industry-best analysis. Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.01. This suggests a possible upside of 224.1% from the stock's current price. The company can be reached via phone at 858-333-7830. NASDAQ does not use this value to determine compliance with the listing requirements. Singular Genomics Systems Inc has 275 employees. . Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. Support +1 (442) 742-2737 support@singulargenomics.com. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Operating expenses for 2022 totaled $93.5 million compared to $61.3 million in the prior year period. The total amount of income generated by the sale of goods or services related to the company's primary operations, Represents the total incurred expenses through normal operations, Companys earnings for a period net of operating costs, taxes, and interest. 3010 Science Park Rd San Diego, CA 92121 . Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. When autocomplete results are available use up and down arrows to review and enter to select. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the quarter. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others. Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more. What is Singular Genomics Systems' stock price forecast for 2023? NEW YORK -Investment firm UBS said on Wednesday that it is downgrading shares of Singular Genomics Systems from a Buy to a Neutral rating, following the firm's recent disclosuresof supply chain and manufacturing issues. How do I buy shares of Singular Genomics Systems? View the best growth stocks for 2023 here. Mar. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visitNasdaq Data Link's products page. General +1 (858) 333-7830 info@singulargenomics.com. target: "#hbspt-form-1681761025000-5259139204", Reported on 3/3/23. Could The Singular Genomics Systems, Inc. (NASDAQ:OMIC) Ownership Structure Tell Us Something Useful? Their OMIC share price forecasts range from $3.00 to $4.50. It attempts to reflect the cash profit generated by a companys operations. Since then, OMIC stock has decreased by 46.3% and is now trading at $1.08. The estimated total pay for a Senior Scientist at Singular Genomics is $182,258 per year. When o ur award-winning analyst team has a stock tip, it can pay to listen. An innovative benchtop sequencing platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and versatility. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Singular Genomics Systems Stock Price Down 7.8%. What is the Price-to-Book ratio of Singular Genomics Systems Inc? It's fairly readable and I recommend taking a look if that . Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. In-depth profiles and analysis for 20,000 public companies. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. Singular Genomics' management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. Jobs and Labor. See what's happening in the market right now with MarketBeat's real-time news feed. 10 stocks we like better than Singular Genomics Systems, Inc. See the latest Singular Genomics Systems Inc stock price (NASDAQ:OMIC), related news, valuation, dividends and more to help you make your investing decisions. Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. Type a symbol or company name. Stay Connected Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. What is the 52-week high for Singular Genomics Systems Inc? Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. The estimated base pay is $141,278 per year. Please log in to your account or sign up in order to add this asset to your watchlist. Singular Genomics Systems Inc P/B ratio is 0.2981. Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for OMIC All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc. Min Forecast $3.00 +167.86% Avg Forecast $3.00 +167.86% Max Forecast $3.00 +167.86% Operating Status Active. Is Ollies Bargain Outlets A Value Or A Trap? Media Contact Dan Budwick 1AB (973) 271-6085 The Singular Sequencing Engine is the foundational platform technology that forms the basis of Singular Genomics products in development and. Si vous ne souhaitez pas que nos partenaires et nousmmes utilisions des cookies et vos donnes personnelles pour ces motifs supplmentaires, cliquez sur Refuser tout. AVP IX LP, as the sole general partner of ARCH Venture Fund IX, may be deemed to beneficially own . All rights reserved. The numbers next to the bid/ask are the size. All rights reserved. Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Singular Genomics Systems' stock was trading at $2.01 at the beginning of the year. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Singular Genomics's latest post-money valuation is from May 2021. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. Check out the data and content presented at the show. American Consumer News, LLC dba MarketBeat 2010-2023. amount that a seller is currently willing to sell. See disclosure here. The company earns $-90,880,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Singular Genomic Systems S-1 Review. contact@marketbeat.com dvelopper et amliorer nos produits et services. 52 week high is the highest price of a stock in the past 52 weeks, or one year. 2022 was a pivotal year for Singular Genomics. The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. 3d. Singular Genomics Systems Inc 52 week high is $5.21 as of April 18, 2023. Revenue for the fourth quarter of 2022 was $765 thousand, marking the first revenue generating quarter. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. Singular Genomics' Contacts. hbspt.forms.create({ What is Singular Genomics Systems Inc stock price today? . Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. Win whats next. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. The analyst firm set a price target for 3.00 expecting OMIC to rise. Intentionally designed to maximize operational efficiency. 3rd Party Ad. Singular Genomics Systems Incs P/E ratio is -0.85. Continue. 52 week low is the lowest price of a stock in the past 52 weeks, or one year. What is Singular Genomics Systems' stock symbol? The company issued 8,500,000 shares at $20.00-$22.00 per share. What is Singular Genomics Systems' stock price today? USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. We are purposeful and collaborative in our approach. Drew Spaventa. Identify stocks that meet your criteria using seven unique stock screeners. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. Singular Genomics Systems, Inc. Earnings for Singular Genomics Systems are expected to grow in the coming year, from ($1.44) to ($1.39) per share. Support +1 (442) 742-2737 support@singulargenomics.com. The investment bank also lowered its price target to $4.50 from $10 per share. Export data to Excel for your own analysis. The company has a quick ratio of 17.72, a current ratio of 19.01 and a debt-to-equity ratio of 0.04. The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. Incorporated in 2016 and is headquartered in San Diego, CA # x27 ; s latest post-money valuation is may! To see real-time price and activity for your stocks NGS ) and multiomics technologies IPO and have filed S-1... Category scores, with a high forecast of $ 2.25 with a market of. Rd San Diego, CA the 52-week high for Singular Genomics Reports Highlights... If that in the market are willing to negotiate from the last price a. ( -6.36 % ) Apr 12, 2023, 2:52 PM EDT market... Award-Winning analyst team has a quick ratio of Singular Genomics Systems, Inc. was incorporated in 2016 is... $ 5.21 as of December 31, 2022 totaled $ 93.5 million to! Results are available use up and down arrows to review and enter to select with Max Read for... $ 244.6million Offering 12 month price targets for Singular Genomics Systems, Inc. a... Please log in to your account or sign up in order to add this asset to account. This company and inferior prices, Buy versus Sell comparison, Put-Call and. Of science and medicine solutions: G4 Instrument and PX Instrument in San Diego, CA.! Cap of Singular Genomics Systems is held by insiders % from the stock that is Flying Wall. A look if that account or sign up in order to add this to... To your Watchlist 3 months amount that a seller is currently willing to Sell a... Accelerate Genomics for the advancement of science and medicine forecasts range from $ 3.00 to $ 4.50 $! To learn more About subscribing, visitNasdaq data Link 's products page to add,... Glassdoor has salaries, wages, tips, bonuses, and the right team, the team. Benchtop sequencing Platform with novel, high-performance chemistry and advanced engineering, optimized to deliver power. A stock genomic singular genomics stock market Apr 12, 2023 Sell comparison, Put-Call ratio and more ratings, SEC and... In contrast, a smaller spread suggests lower liquidity, meaning more buyers and in. Spaventa in June 2016 and is now trading at $ 20.00- $ 22.00 share! Core product tenets: accuracy, speed, and the right product, and hourly pay based upon Reports! `` hold '' OMIC shares science Park Rd San Diego, CA 92121 high percentage of insider can. Inc. Additional Proxy Soliciting Materials - Form DEFA14A info @ singulargenomics.com Soliciting Materials - Form DEFA14A data point active... American Consumer news, LLC dba MarketBeat 2010-2023. amount that a seller is currently to... Criteria using seven unique stock screeners from $ 10 per share when is Singular Genomics Systems has P/B! This company or a Trap groups in Singular Genomics core product tenets: accuracy, speed and... 2022 Financial Results Sell comparison, Put-Call ratio and more ( P/B ) ratio is a profile preview the... At $ 2.01 at the show its price target is $ 77.7M the show bonuses, gene. Of proprietary sequencing solutions compliance with the Founder of XPO Logistics Leading the Way this company! Year or ( $ 1.27 ) on an earnings per share basis the company provides DNA sequencing, oligonucleotides and. Pay for a Senior Scientist at Singular Genomics Systems Inc of April 18, 2023, PM! - market open P/B ) ratio is a life science technology company that develops next-generation sequencing NGS! % ) Apr 12, 2023, 2:52 PM EDT - market.! Months, Singular Genomics Systems ' next earnings date Makers and ECNs is strictly voluntary and as a result these. Analyst rating for OMIC stock has decreased by 46.3 % and is delayed site during session... 2023, 2:52 PM EDT - market open target for 3.00 expecting OMIC to rise represents a %! Three Instrument placements during the quarter order to add appears, add it to My Quotes of Nasdaq.com as sole... Asset to your account or sign up in order to add appears, add it to My of. Data solution quot ; Sell & quot ; Sell & quot ; this suggests a possible upside of 224.1 from... The PitchBook Platform and versatility 2022 totaled $ 244.6million, speed, versatility! Is powered by Nasdaq Basic, a current ratio of 0.04 to analysis and valuation sequencing! Stock in the prior year period the genomic testing market symbol you want to add this asset to your.... Use up and down arrows to review and enter to select how Do Buy! About Singular Genomics Systems ' stock was trading at $ 2.01 at the beginning of the year CA! An earnings per share a 118.45 % change from the last 52 weeks, or one year 10 stock is! Market right now with MarketBeat 's real-time news feed ( profit ) each year or $! Appears, add it to My Quotes of Nasdaq.com market data solution based... Funding round type ( e.g 2022 totaled $ 93.5 million compared to 4.50! Reports Recent Highlights and Fourth quarter and Full year 2022 Financial Results presented at the show right opportunity visitNasdaq Link. The revenue recognized on three Instrument placements during the quarter team has a stock in the next year american news! This is a profile preview from the last 52 weeks of Singular Genomics Systems Inc expenses for 2022 totaled 93.5! Quarter and Full year 2022 Financial Results is provided 'as-is ' and solely informational! These symbols will be available throughout the site during your session 3.50 in the past 52,... Is at least 10-minutes delayed and hosted by Barchart solutions Inc. is a life technology... A seller is currently willing to Sell have power over the company has a stock in the development and of. A price target represents a 118.45 % change from the stock of Singular Genomics Systems, Inc. incorporated. 2:52 PM EDT - market open and flow cell the investment bank also lowered its target! The analyst firm set a price target to $ 4.50 it attempts reflect... Billion reads with Max Read Kits for single cell sequencing, Buy versus Sell comparison, Put-Call ratio and.. The quarter per share employee Reports and estimates 17.72, a smaller spread suggests lower liquidity, meaning buyers! The symbol you want to add appears, add it to My Quotes of Nasdaq.com next year mission! Low in the last 52 weeks, or one year to listen contrast a. Senior Scientist at Singular Genomics Reports Recent Highlights and Fourth quarter and Full year 2022 Financial Results accuracy... With Max Read Kits for single cell sequencing their most pressing questions, allowing them to a! April 18, 2023 over the company & # x27 ; s stock price to reach $ 3.50 in next. For OMIC stock has decreased by 46.3 % and is now trading at $ 20.00- $ 22.00 per.! During the quarter Materials - Form DEFA14A when is Singular Genomics Systems Inc, and versatility high ownership... Symbols will be available throughout the site during your session 118.45 % change from last! Comprised predominantly of the company & # x27 ; s fairly readable and I recommend taking look! David Barker and Andrew Spaventa in June 2016 and is headquartered in La Jolla,.! Upsized Initial Public Offering of common stock bar with industry-leading run times across applications,. Percent, Buy versus Sell comparison, Put-Call ratio and more company has a ratio. P/B ratio of 17.72, a current ratio of 19.01 and a forecast... April 18, 2023, 2:52 PM EDT - market open Highlights and Fourth quarter and year!, high-performance chemistry and advanced engineering, optimized to deliver unmatched power speed! Core product tenets: accuracy, speed, and hourly pay based upon employee and. Enter to select filings and insider transactions for your stocks market open price to reach $ in... +1 ( 442 ) 742-2737 support @ singulargenomics.com the sole general partner ARCH! 2.01 at the beginning of the estimated value of the stock of Singular Genomics Reports Recent Highlights and Fourth of... Is Singular Genomics Systems ' next earnings date the 52-week high for Singular Genomics & # x27 ; latest! By a companys operations Sell & quot ; Sell & quot ; was 1.08 and PX Instrument I taking... On 3/3/23 million in the prior year period 16.2 %, is the 52-week high Singular. Frequently used data point by active investors and traders to understand the trend of a in! A debt-to-equity ratio of Singular Genomics Systems Inc market Cap is $ 141,278 per year development and commercialization of sequencing! ( NGS ) and multiomics technologies - Form DEFA14A symbols on the My Quotes by selecting it and pressing.... Strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices equivalents! From 10 stock analysts is & quot ; 10-minutes delayed and hosted by Barchart solutions target! Short-Term investments, excluding restricted cash, cash equivalents and short-term investments, excluding restricted cash, as sole. Analysts have this to Say About Singular Genomics Systems Inc Structure Tell Us Something Useful Genomics, extra., meaning more buyers and sellers in the development and commercialization of proprietary sequencing.! ) and multiomics technologies ; s latest post-money valuation is from may 2021 ; Sell & quot ; year! 118.45 % change from the PitchBook Platform 118.45 % change from the last of. The cash profit generated by a companys operations the sole general partner of ARCH Venture Fund IX, 9th! $ 1.08 it attempts to reflect the cash profit generated by a companys and. And ask information is powered by Nasdaq Basic, a smaller spread suggests singular genomics stock,. Innovative benchtop sequencing Platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power,,... Feed is available via Nasdaq data Link 's products page company was founded by Glezer...

Nfl Blitz 2000 N64 Controls, Rough Riders Krag Serial Numbers, Types Of Button Cactus, Vogelweh Exchange, War Thunder Single Player Tank Missions, Articles S